International Congo bracing for another Ebola Outbreak. 1 in 4 still doesn't believe the virus is real.

Arkain2K

Si vis pacem, para bellum
@Steel
Joined
Dec 6, 2010
Messages
33,423
Reaction score
5,684






Congo to begin Ebola vaccinations on Monday

May 20, 2018



MBANDAKA, Democratic Republic of Congo (Reuters) - Health workers in Democratic Republic of Congo will begin a vaccination campaign on Monday aimed at containing an outbreak of the deadly Ebola virus, a spokeswoman for the health ministry said.

Jessica Ilunga said 4,000 doses of vaccine were shipped on Saturday to Mbandaka, which last week registered the first cases in an urban area since the latest flare-up of the disease was announced earlier this month.

Cases in Mbandaka, a port city on the Congo river, have raised concerns that the virus could spread downstream to the capital Kinshasa, which has a population of 10 million.

The outbreak is Congo’s ninth since the disease made its first known appearance near the vast central African country’s northern Ebola river in the 1970s. An Ebola epidemic killed more than 11,300 people in West Africa in 2013 to 2016.

The World Health Organization (WHO) said on Friday that Ebola — which causes hemorrhagic fever, vomiting and diarrhea and is spread through direct contact with body fluids from an infected person — had killed 25 people since early April.

Confirmation of the disease in Mbandaka, a city of about 1.5 million people, prompted the WHO last week to declare a “very high” public health risk for the country and a “high” risk for the region. But it said the outbreak could be brought under control and was not yet an international public health emergency.

“Previous outbreaks have demonstrated the importance of a rapid and well-resourced response in order to save lives, but also prevent an exponential increase in the economic cost of a response,” WHO spokesman Tarik Jasarevic said on Sunday.

The U.N. health body was heavily criticized as too slow to declare an international emergency during the 2013-2016 epidemic that spread through Guinea, Sierra Leone and Liberia and infected nearly 30,000 people.

Jasarevic said the WHO was seeking $26 million to fund the Ebola response in Congo.

aHR0cDovL3d3dy5saXZlc2NpZW5jZS5jb20vaW1hZ2VzL2kvMDAwLzA5OS84NjYvb3JpZ2luYWwvZWJvbGEtdmFjY2luZXMtTk8tUkVVU0U=

Congolese Health Ministry officials carry the first delivery of Ebola vaccines in Kinshasa, Democratic Republic of Congo on May 16


The WHO is sending 7,540 doses of the vaccine developed by Merck to Congo. It is also in talks about a second vaccine made by Johnson & Johnson.

More than 30 health workers with experience administering Ebola vaccines are being deployed from Guinea to help with the campaign in Congo. Logistical difficulties remain, especially the need to keep the vaccine 80 degrees Celsius below freezing in a humid region where daytime temperatures hover around 30 and power supplies are erratic.

A government spokesman said late on Saturday that Congo’s partners had promised to make available 300,000 doses of vaccine.

https://www.reuters.com/article/us-...erests-with-eu-on-iran-concerns-idUSKCN1IL016
 
Last edited:
As usually I can’t bring myself to give a fuck about Africa.
 
Hope the vaccine works. Congo has enough problems to deal with as it is.
 
Experimental Ebola vaccine shipped to Congo
May 18, 2018



Health officials remain hopeful that an experimental Ebola vaccine will help control the outbreak sweeping the Democratic Republic of Congo in central Africa.

Since April 4, 45 hemorrhagic fever cases have been reported, including 25 deaths, the health ministry said Thursday. Fourteen of those cases are confirmed to be Ebola virus disease, 10 are suspected and 21 are probable.

The WHO has deployed doses of the experimental vaccine along with emergency teams and equipment Congo. There are more than 5,000 doses of vaccine in Kinshasa, the country’s capital, and health officials are expecting another batch of about 4,000 doses, said James Fulker, a spokesman for the international organization Gavi: the Vaccine Alliance.

“Most of the time, Ebola is contained purely by public health measures. So this is the first time that a vaccine that has been shown to have efficacy is being employed in the control of Ebola. So in that respect it’s unique,” said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases in the United States, who oversees an extensive research portfolio that includes studies on the Ebola virus.

Between 2015 and 2016, the experimental vaccine was given to people in Guinea who were in contact with patients who had recently confirmed cases of Ebola, according to a study on that trial published in the journal The Lancet. The estimated vaccine efficacy in that study was 100%.
Now, for the vaccine, it’s showtime once again — and because the vaccine is experimental, meaning it’s still being studied, it is administered with strict protocols hinging on informed consent.
How the vaccine works

The vaccine — called rVSV-ZEBOV — must be kept between -60 and -80 degrees Celsius (-76 to -112 degrees Fahrenheit) and are believed to last two weeks under basic refrigeration.

Cold storage in Mbandaka — a city of nearly 1.2 million people in Equateur Province in northwestern Congo — is in the process of being set up. The latest case of Ebola virus disease was confirmed Thursday in Wangata, one of the three health zones of Mbandaka.

There are multiple strains of the Ebola virus. For instance, the three species Zaire ebolavirus, Bundibugyo ebolavirus and Sudan ebolavirus are responsible for the larger Ebola outbreaks in Africa. This vaccine covers those in the Zaire group.

“It works by inducing in the body a response that can protect against the Ebola virus. It’s usually an antibody response, namely a protein that the body induces to be able to protect against Ebola,” Fauci said.

“Right now, there are still vaccine trials that are going on. Originally, the vaccine was shown to have some efficacy when it was used in a ring vaccination in Guinea, but the trials that went on in Sierra Leone and Liberia were merely to prove safety and whether or not it induced an immune response that you might predict would be protective,” he said.
The vaccine, from the pharmaceutical company Merck, is used in a ring vaccinations strategy: vaccinating the close contacts of Ebola cases and the contacts of those contacts, such as family members; a buffer or “ring” of immune people around those who are sick can keep the disease from spreading.

In addition to the rings, Ebola health care workers and front line works are vaccinated, said Ira Longini, a biostatistician at the University of Florida in Gainesville, who was part of the research team leading the Ebola vaccine trials.

Anyone receiving the vaccine will then be checked three, 14, 21, 42, 63 and 84 days later.

“The estimated efficacy during the trial was 100%, and it’s pretty much that simple. It protects you against illness if you’re vaccinated before you’re infected,” Longini said.
“There’s no effective treatment against Ebola. It has about a 50% death rate for those who become ill, so there’s very little we can do except vaccinate, and so the vaccine is very important,” he said. “In addition, the vaccine not only protects those who are vaccinated but also those around those who are vaccinated. It affects them indirectly, so it can be quite effective in stopping an outbreak or preventing the outbreak from getting large.”
‘This particular vaccine … does look hopeful’

The ring vaccination strategy was used against smallpox in the 1970s, until it was officially declared eradicated in 1980.

“So the strategy’s been used before, and it’s been used successfully,” said Dr. Daniel Lucey, a senior scholar with the O’Neill Institute for National and Global Health Law and adjunct professor of medicine-infectious disease at Georgetown Law, who is a spokesman for the Infectious Diseases Society of America.

Regarding the Ebola vaccine, “as I understand from comments from the World Health Organization and Democratic Republic of Congo this week, it will be used not surprisingly in the same way that it was first studied during the West African Ebola outbreak initially in Guinea,” said Lucey, who has treated Ebola patients during outbreaks in Sierra Leone and Liberia.

“This particular vaccine, although it’s still experimental, does look hopeful from past experience in Guinea and Sierra Leone, but we don’t know for sure,” he said. “If in fact it is safe and effective, it really will be a game-changer in terms of being able to more quickly stop future Ebola epidemics.”

This vaccine isn’t the only Ebola vaccine out there. There are multiple Ebola vaccine candidates in development, including the cAd3-EBOZ vaccine, which was found to be well-tolerated and induced an immune response, according to findings presented in February 2016.

Ebola virus disease, formerly known as Ebola hemorrhagic fever, is spread through direct contact with bodily fluids of a person who is sick with or has died from the disease.

“It never spreads through the air, thankfully,” Lucey said.

“So the idea is to vaccinate people who come into contact or are in contact of people who come into contact with people who have Ebola virus infection,” he said. “And importantly, this vaccine can never cause Ebola disease, because it contains only one small part of the Ebola virus, so it could never cause the disease itself.”

West Africa experienced the largest recorded outbreak of Ebola over a two-year period beginning in March 2014. A total of 28,616 confirmed, probable and suspected cases were reported in Guinea, Liberia and Sierra Leone, with 11,310 deaths, according to the WHO.

Last week, the government of the Democratic Republic of Congo declared the current Ebola outbreak, its ninth since the discovery of the virusnear the country’s Ebola River in 1976.

“Right now, it is impossible to tell what’s going to happen with this. Is it going to be a big outbreak? Is it going to be a medium outbreak or a small outbreak? … We don’t know at this point. That’s why we’re treating it as a very serious situation,” Fauci said.

“I think the important takeaway message is that in the outbreak that took place in western Africa, we were able to be able to develop a vaccine and show that it works,” he said. “So right now, this is a good example that you can and should be able to do research that tests the efficacy of products during an outbreak, the way it was done in West Africa.”

http://q13fox.com/2018/05/18/experimental-ebola-vaccine-shipped-to-congo/
 
Last edited:
As usually I can’t bring myself to give a fuck about Africa.

Incredible insight on the subject matter.

Now get the fuck out and don't ever step into any of my threads with these utterly worthless "contribution" again.
 
Last edited:
Sounds like a really shit way to die, hopefully it doesn't spread too much.
 
Africa is the population bomb, and it is exploding. Perhaps this is the natural order of things to keep things in balance?

file-20171009-6979-1f8z2f2.png
 
Africa is the population bomb, and it is exploding. Perhaps this is the natural order of things to keep things in balance?

file-20171009-6979-1f8z2f2.png

any plague that runs rampant in africa sooner rather than later spreads to the world.
 
why is ebola popping up again, is it mutating.

What is Ebola? The new outbreak in Congo explained
Ebola crops up regularly across the tropical zones of Africa, so it’s clear that it survives in reservoirs of forest animals. Bats are the No. 1 suspect, but it’s unlikely bat bites cause every outbreak. Bush meat is one possibility — Ebola can infect apes and monkeys, and people in affected areas often hunt these animals for food. Antelope and porcupines also can spread Ebola when slaughtered. One thing is clear — once there is an outbreak, it’s spread from person to person.

https://www.nbcnews.com/storyline/e...at-ebola-new-outbreak-congo-explained-n875521
 
Last edited:
Ooooof.... Don't eat that bush meat.
 
When everyone said Africa has ebola few years back when this happened.

images
 
They gotta stop eating the local monkeys for bush meat.
 
experimental vaccines sounds like a zombie movie in the making.
 
any plague that runs rampant in africa sooner rather than later spreads to the world.


Not ebola. It would be contained quickly in any 1st world nation. In many African communities where Ebola thrives it is because the populace doesn't understand how diseases are transmitted. They kiss and touch and handle the deadly infected bodies that are covered in the virus. They hold funerals that are many days long with the infectious corpse infected many of them. They have communal washing bowls they use to wash their hands after touching the corpse which spreads the deadly virus.

In the 1st world we quarantine the corpse and sterilize the area. Ebola transmits through direct contact with fluids. It is easy to contain for populations that understand science and are literate and live in what we consider modern times.
 
Back
Top